Rising tech valuations put pressure on VC exits

Holding periods lengthen to eight years. by mergermarket

Obama plan for Alzheimer’s research expected to see Congressional pushback in light of tight budgets, sources say

New funds would be geared towards basic science research. by BioPharm Insight

Pfizer’s arthritis drug tofacitinib to receive positive FDA AdCom recommendation in May, safety concerns to be discussed

Drug’s effect on lipid levels and liver toxicity among key safety concerns for discussion. by BioPharm Insight

MMI wins injunction against Microsoft in Germany

Microsoft will likely appeal this decision. by dealReporter

Reliance Protectron in midst of sale process

The company has hired Goldman Sachs to run the process. by mergermarket

InterDigital selling packages of patents

Patent portfolio split into separate bundles for renewed sale effort. by dealReporter

Collective Brands’ suitor list narrows, bids due later this week

Sale process deliberately moves forward. by dealReporter

Indian competition regulator likely to take hands-off approach to pharma

Price controls were heavily discussed by government. by dealReporter

Apple and four publishers in settlement talks with European Commission

Penguin understood to be only defendant in EC probe not to have made settlement proposal. by dealReporter

Roche’s Zelboraf steadily adopted in advanced melanoma

Antitrust a buzz word at China’s parliamentary meeting

China’s vast shale gas potential limited by pipeline infrastructure obstacles

Lundbeck’s alcoholism drug faces EU regulatory challenges

Generali cash call conflict could push it to consider hybrids

TNT Express/UPS regulatory probe could examine increased risk of collusion

Internet lobby would opt for political fight over new data costs

Fal Oil may be facing threat of legal action from one of its creditors

Arab Spring creates groundswell of potential FCPA action

Turkey’s new commercial code to have broad impact on M&A

Party City starts dual-track sale process

Verizon deal tees up battle over spectrum screen

Key members of Congress aim to pass legislation on China CVD by mid-March

EDF would prefer to keep Edison listed, CEO says

Banks sounding Galaxy Entertainment block sale from Permira

Georgia Gulf deadline key to deciphering Westlake strategy

Yahoo: Alibaba remains in complicated split talks

McGraw-Hill preps education auction, sources say

Spectrum fight in final rounds on Capitol Hill

Pfizer: Danone and Mead Johnson consider team-up for nutrition bid

Gilead not immune to concern over Truvada’s wider HIV use

Genex Services in sale process through Bank of America

Germany’s tough reimbursement rules cause drug companies to consider alternative drug trial solutions

Novellus top convertible issuance in dealReporter poll

Italy’s Monti says no plans to sell government stakes in Italian companies

Erdenes Tavan Tolgoi mulls dropping Hong Kong portion of USD 3bn IPO

Landmark China antitrust settlement opposed by adviser

Korean IPO resilience to continue in 2012

Drydocks World restructuring talks unlikely to be impacted by Monarch lawsuit

Commercial Metals/Icahn strap in for long ‘cat fight’

The EC to slam Google with 400+ page SO

Dollar Thrifty/Hertz remedy package lined up amid FTC impatience

Unicredit rights offering lures underwriters despite risk

SonoSite bidders home in on multiple, ‘call points’, sources say

CoreLogic’s complex sale process advances

Yahoo: Microsoft signs NDA

Gilead’s ‘big bet’ on Pharmasset hinges on future results

Antitrust chiefs cite transparency, tout growing tech prowess

PepsiCo opening up to advice on alternatives, bankers say

Computer Sciences activist shake-up chatter heats up